Literature DB >> 25722649

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation.

Lise J Estcourt1, Gemma L Crighton2, Erica M Wood3, Simon Stanworth1, Marialena Trivella4, Carolyn Doree5, Alan Tinmouth6, Michael F Murphy7.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To determine whether a therapeutic-only platelet transfusion policy (platelet transfusions given when patient bleeds) is as effective and safe as a prophylactic platelet transfusion policy (platelet transfusions given to prevent bleeding usually when the platelet count falls below a given trigger level) in patients with haematological disorders undergoing myelosuppressive chemotherapy or stem cell transplantation.

Entities:  

Year:  2014        PMID： 25722649      PMCID： PMC4338539          DOI： 10.1002/14651858.CD010981

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  50 in total

1.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

Review 2.  Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review.

Authors:  Nancy M Heddle; Donald M Arnold; Diana Boye; Kathryn E Webert; Ilona Resz; Larry J Dumont
Journal:  Transfusion       Date:  2008-05-13       Impact factor: 3.157

Review 3.  Platelet transfusions for patients with haematological malignancies: who needs them?

Authors:  Lise J Estcourt; S J Stanworth; M F Murphy
Journal:  Br J Haematol       Date:  2011-05-25       Impact factor: 6.998

4.  The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study.

Authors:  D J Higby; E Cohen; J F Holland; L Sinks
Journal:  Transfusion       Date:  1974 Sep-Oct       Impact factor: 3.157

Review 5.  Controversies in platelet transfusion therapy.

Authors:  S J Slichter
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

6.  Platelet prophylaxis in acute non-lymphoblastic leukaemia.

Authors:  J Solomon; T Bofenkamp; J L Fahey; R K Chillar; E Beutel
Journal:  Lancet       Date:  1978-02-04       Impact factor: 79.321

Review 7.  Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.

Authors:  Alexander B Benson; Marc Moss; Christopher C Silliman
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

Review 8.  Evidence-based platelet transfusion guidelines.

Authors:  Sherrill J Slichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2007

9.  Practical methods for incorporating summary time-to-event data into meta-analysis.

Authors:  Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes
Journal:  Trials       Date:  2007-06-07       Impact factor: 2.279

10.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001.

Authors:  M P Coleman; B Rachet; L M Woods; E Mitry; M Riga; N Cooper; M J Quinn; H Brenner; J Estève
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640
View more
  3 in total

Review 1.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18

Review 2.  Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.

Authors:  Michael Desborough; Lise J Estcourt; Carolyn Doree; Marialena Trivella; Sally Hopewell; Simon J Stanworth; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2016-08-22

Review 3.  Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon Stanworth; Carolyn Doree; Marialena Trivella; Sally Hopewell; Patricia Blanco; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.